Tag Archives: Penn Medicine

Biopharma, Blue Shield Blue Cross, Rare/Orphan Disease, Specialty Drug

Independence Blue Cross Launches Gene Therapeutics Network

Posted on by John Santilli
BlueCross Blue Shield Plans: Access Market Intelligence
31
Jan

Independence Blue Cross (Independence) recently announced the launch of its Advanced Network for Gene-Based Therapeutics, which will be effective March 1, 2023

Continue reading →
Infusion, Specialty Pharmacy

CVS Health’s Coram Accelerating Acceptance of Home-Based Chemotherapy with CTCA

Posted on by John Santilli
14
Jan

Home infusion specialty services have been positioned for expansion into chemotherapy as they have been integrating into payer infrastructures over time

Continue reading →